Skip to content
10-Q

Quarterly Report

TARSUS PHARMACEUTICALS, INC. TARS

0001819790-25-000108

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 42.21M sh
Shares Diluted Q2 2025 · Jun 30, 2025 42.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 40.87M sh
Shares Diluted Q2 2025 · Jun 30, 2024 37.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.53M sh
Capex Q2 2025 · Jun 30, 2025 $1.59M
Capex Q2 2025 · Jun 30, 2024 $1.21M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$50.04M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$52.19M
Long Term Debt Q2 2025 · Jun 30, 2025 $72.13M
Long Term Debt Q2 2025 · Dec 31, 2024 $71.85M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $96.65M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $94.82M
Stockholders Equity Q2 2025 · Jun 30, 2025 $332.61M
Stockholders Equity Q2 2025 · Mar 31, 2025 $342.46M
Stockholders Equity Q2 2025 · Dec 31, 2024 $224.53M
Stockholders Equity Q2 2025 · Jun 30, 2024 $252.25M
Stockholders Equity Q2 2025 · Mar 31, 2024 $275.21M
Stockholders Equity Q2 2025 · Dec 31, 2023 $196.99M
Current Liabilities Q2 2025 · Jun 30, 2025 $90.25M
Current Liabilities Q2 2025 · Dec 31, 2024 $80.61M
Total Liabilities Q2 2025 · Jun 30, 2025 $162.38M
Total Liabilities Q2 2025 · Dec 31, 2024 $152.46M
Current Assets Q2 2025 · Jun 30, 2025 $474.43M
Current Assets Q2 2025 · Dec 31, 2024 $356.71M
Total Assets Q2 2025 · Jun 30, 2025 $494.99M
Total Assets Q2 2025 · Dec 31, 2024 $376.99M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.48
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.88
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.89
Eps Basic Q2 2025 · Jun 30, 2025 −$0.48
Eps Basic Q2 2025 · Jun 30, 2025 −$1.11
Eps Basic Q2 2025 · Jun 30, 2024 −$0.88
Eps Basic Q2 2025 · Jun 30, 2024 −$1.89
Sga Expense Q2 2025 · Jun 30, 2025 $103.01M
Sga Expense Q2 2025 · Jun 30, 2025 $188.01M
Sga Expense Q2 2025 · Jun 30, 2024 $58.79M
Sga Expense Q2 2025 · Jun 30, 2024 $110.37M
Rd Expense Q2 2025 · Jun 30, 2025 $15.59M
Rd Expense Q2 2025 · Jun 30, 2025 $30M
Rd Expense Q2 2025 · Jun 30, 2024 $12.32M
Rd Expense Q2 2025 · Jun 30, 2024 $24.39M
Net Income Q2 2025 · Jun 30, 2025 −$20.34M
Net Income Q2 2025 · Jun 30, 2025 −$45.46M
Net Income Q2 2025 · Mar 31, 2025 −$25.12M
Net Income Q2 2025 · Jun 30, 2024 −$33.29M
Net Income Q2 2025 · Jun 30, 2024 −$69.02M
Net Income Q2 2025 · Mar 31, 2024 −$35.73M
Operating Income Q2 2025 · Jun 30, 2025 −$22.18M
Operating Income Q2 2025 · Jun 30, 2025 −$48.46M
Operating Income Q2 2025 · Jun 30, 2024 −$33.3M
Operating Income Q2 2025 · Jun 30, 2024 −$70.99M
Revenue Q2 2025 · Jun 30, 2025 $102.66M
Revenue Q2 2025 · Jun 30, 2025 $181M
Revenue Q2 2025 · Jun 30, 2024 $40.81M
Revenue Q2 2025 · Jun 30, 2024 $68.43M